| CASE REPORT |
|
| Year : 2016 | Volume
: 3
| Issue : 2 | Page : 141-143 |
|
|
Neuroleptic malignant syndrome induced by concomitant use of risperidone and quetiapine
Mustafa Volkan Demir1, Tuba Ozturk Demir2, Selcuk Yaylaci3, Huseyin Yildiz1, Ibrahim Tayci1, Mustafa Baydar1
1 Department of Internal Medicine, Malatya State Hospital, Malatya, Turkey
2 Department of Emergency Medicine, Faculty of Medicine, University of Inonu, Malatya, Turkey
3 Department of Internal Medicine, Rize Findikli State Hospital, Rize, Turkey
Correspondence Address:
Mustafa Volkan Demir
Department of Internal Medicine, Malatya State Hospital, Malatya
Turkey
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2348-3334.177643
|
|
|
Neuroleptic malignant syndrome (NMS) is a rare but life-threatening condition induced by neuroleptic medications. In severe cases, NMS can rapidly lead to death. NMS is reported less frequently now-a-days with the advent of new antipsychotic drugs. We discuss 20-year-old male patient with NMS induced by risperidone and quetiapin. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
